Does Insurance Cover Duavee? What Real 2026 Plan Policies Require

Last verified: July 28, 2026 · Editorial research — not reviewed by a clinician. Our medical review policy. Affiliate disclosure.

Does insurance cover Duavee? Yes, plans do cover it — but coverage is conditional, not automatic. Your exact plan may cover it outright, cover it only after prior authorization or step therapy, cap the quantity, or leave it off the formulary and require a written exception. Duavee appears on the 2026 Express Scripts National Preferred Formulary, though that list does not guarantee coverage under your plan.

Here’s the part that surprised us. We pulled the actual 2026 coverage policies three insurers use for Duavee and lined them up. One wants seven hot flashes a day plus a failed antidepressant trial. One wants two failed estrogens. One doesn’t ask about estrogens at all — it asks a completely different question, and if you answer that one correctly, you may skip the rest.

Same drug. Same woman. A different answer at every plan we read. That’s why “is Duavee covered?” has no honest one-word answer, and why pages telling you it’s “usually Tier 3” aren’t helping. Your plan is applying one specific written rule. That rule is knowable, usually in about five minutes, and the sentence that unlocks it is often the exact reason you were put on Duavee in the first place.

Which lane are you in?

Find your row first. Your insurance type changes almost every answer below.

Pfizer’s savings card excludes Medicare, Medicaid, TRICARE, VA, state pharmaceutical assistance programs, and cash-paying patients. From the card’s own published terms, read July 28, 2026.

Start here — it’s the fastest thing on this page

The Duavee Ladder: what real payer policies require

We read four 2026 coverage documents side by side. Here’s every row, exactly as written.

Sources: BCBS Arizona Pharmacy Coverage Guideline P140.2 (reviewed 11/20/2025); Centene CP.PMN.258 (reviewed 02/2026); Kaiser Foundation Health Plan of the Northwest criteria (revised 01/08/2026); *fourth criteria document dated 02/23/2026, issuer not identified in the document. All read in full on July 28, 2026.

Read the “must document first” row again. One plan asks you to document a failed antidepressantbefore it will pay for an FDA-approved hormone therapy. Kaiser — which doesn’t even carry Duavee on its formulary — never asks how many estrogens you’ve tried. It asks whether you can tolerate progestogens. That’s the whole game.

What does my plan actually require before it will cover Duavee?

Requirements vary widely. All four policies require an intact uterus and prior authorization. Beyond that: one requires two estrogen trials plus an antidepressant trial; one requires two formulary estrogen products with exceptions for contraindications; one requires progestogen contraindication or two documented progestogen failures; and one requires no step therapy at all.

The plan that wants seven hot flashes a day

Blue Cross Blue Shield of Arizona’s guideline, last reviewed November 20, 2025, is the most demanding we found. You need to be a woman aged 18 to 75 with an intact uterus, averaging at least seven moderate-to-severe hot flashes per day. Then you need documented failure, intolerance, contraindication, or ineligibility for two low-dose estrogen products and onelow-dose antidepressant — paroxetine, citalopram, or escitalopram.

Read that again. A documented antidepressant trial before an FDA-approved hormone therapy.

For renewal, the BCBS Arizona policy asks for documentation of at least a 50% reduction in both frequency and severity of hot flashes, plus evidence of adherence. Know that before approval, not after.

The plan with the twelve-month trials

Centene’s clinical policy, last reviewed February 2026, applies to the Health Insurance Marketplace and Medicaid lines of business named in the document. For hot flashes, the bar is lower: a diagnosis, an intact uterus, and documented failure of two formulary estrogen products — unless they’re contraindicated or caused clinically significant adverse effects.

Hold onto that last clause. That’s the door. For bone protection, the policy asks for documentation of a 12-month oral bisphosphonate trial and a 12-month raloxifene trial, subject to those same exceptions.

Small good news in the revision log: Centene raised initial approval from 6 months to 12 in its first-quarter 2026 review. Half as many renewals.

The plan that asks a completely different question

Kaiser Permanente Northwest doesn’t carry Duavee on its formulary. On paper that sounds worse. In practice, its criteria — revised January 8, 2026, effective March 5, 2026 — take a different route. Kaiser covers Duavee for 12 months when you have hot flashes severe enough to interfere with daily activities or sleep, an intact uterus, and either:

• a contraindication to progestogens, or
• you are stable on a systemic estrogen at a dose roughly equivalent to 0.45 mg conjugated equine estrogens and have tried and failed two different progestogens due to defined intolerance

No estrogen count as a hurdle. No antidepressant. Quantity limits do apply.

Two more details from that document: For members already on Duavee who haven’t been reviewed before, the policy asks for one failed progestogen, not two.And starting at age 65, if symptoms have fully resolved, the policy calls for a trial off medication every two years to see whether treatment is still necessary. That’s a scheduled re-check, not a denial.

And one that asks for almost nothing

The fourth document, dated February 23, 2026, requires prior authorization and a quantity limit — and that’s about it. Age 18 to 75, intact uterus, an approved use, no contraindications. No step therapy for hot flashes. Its existence proves something worth holding onto: a Duavee denial is not inevitable. Some 2026 policies just cover it.

The word that decides your case: “intolerance”

Kaiser Permanente Northwest expressly uses progestogen contraindication or documented progestogen intolerance as its approval route, and defines intolerance narrowly — excluding reactions that were expected, mild, resolved with continued treatment, did not require stopping the medication, or could likely have been relieved by adjusting dose. The specific symptoms it names as counting: bleeding, breast tenderness, and cognitive or mood symptoms tied to the progestogen component.

Here’s what that means at your kitchen table.

You’re not exaggerating by being specific. You’re translating. Insurers read charts, not feelings, and the details that felt too small to mention are often exactly what the written criteria ask for.

Bring these five things to your appointment

Copy this. Fill it in before you go. Hand it to your prescriber’s office so they can lift the details straight into the prior authorization form.

The samples trap

If your prescriber handed you a few weeks of Duavee samples, that was kind. It may also have produced no usable documentation.Blue Cross Blue Shield of Arizona’s policy states it plainly: it does not accept patient use of samples as evidence of a treatment course, as justification for continuing therapy, or as proof of an adequate trial and failure.

Sample availability also changed — Pfizer’s professional site showed no Duavee samples available when we checked on July 28, 2026. If you’re on samples right now, start the prior authorization today. The paperwork clock and the sample supply are two separate timelines, and only one is in your control.

How much does Duavee cost with insurance?

“Covered” does not determine what you pay. Your out-of-pocket cost depends on your plan’s negotiated price, whether your deductible is met, the formulary tier, whether the plan uses a flat copay or percentage coinsurance, your pharmacy, the quantity dispensed, and whether an eligible savings card applies. Only a claim run at your pharmacy produces your real number.

Five variables set your price:

1. Deductible status. Before your deductible is met, many plans have you pay the full negotiated price. That’s why January prices look nothing like June prices.
2. Tier. A non-preferred brand tier costs more than a preferred one. There is no verified national “typical tier” for Duavee — we’re not going to invent one.
3. Copay vs. coinsurance. A flat copay is predictable. Coinsurance is a percentage of a price you don’t control, and for a brand-only drug that’s a meaningful difference.
4. Pharmacy. Preferred, standard, and mail-order pharmacies can produce three different numbers for the same prescription on the same plan.
5. Card eligibility. Only if you have commercial insurance that covers Duavee — see the math below.

Does Medicare cover Duavee?

Duavee is a self-administered oral prescription, so Medicare coverage runs through a Part D or Medicare Advantage drug plan rather than standard Part B. Coverage, tier, and utilization rules vary by the exact plan and can change each plan year. The Pfizer savings card cannot be used by anyone with Medicare.

The 2026 numbers changed, and many pages still quote last year’s:

• Maximum Part D deductible in 2026: $615. Some plans charge less, or none.
• Annual out-of-pocket cap for covered drugs: $2,100 (up from $2,000). Once you reach it, you pay $0 for covered drugs for the rest of the year.
• The old coverage gap — the “donut hole” — is gone.

To check your plan:use Medicare Plan Finder, add Duavee at the exact dose and quantity, add your preferred pharmacies, and record whether it’s covered, its tier, restrictions, and estimated annual cost. Then confirm in your member portal — Plan Finder and plan documents occasionally disagree.

If Duavee isn’t on your formulary, you can request a formulary exception. You, your authorized representative, or your prescriber can request a coverage determination or exception — and a formulary exception requires a supporting statement from your prescriber establishing that covered alternatives would be less effective or cause adverse effects.

See the CMS Part D exceptions process and Medicare appeals in a drug plan.

Does Medicaid cover Duavee?

Medicaid drug coverage is determined by your state, your fee-for-service program, or your managed care plan. Duavee may be covered, non-preferred, excluded, or subject to prior authorization. The Pfizer commercial savings card cannot be used with Medicaid.

There’s no national Medicaid answer, and anyone giving you one is guessing. Here’s how to get yours in about ten minutes:

1. Find out whether you’re in fee-for-service Medicaid or a managed care plan.
2. Search your state Medicaid agency’s site for the preferred drug list.
3. Search separately for the prior authorization criteria library — these usually live in a different document from the drug list.
4. Download the official PA form for your state.
5. Note the approval length and any quantity limit, and put the renewal date in your calendar the day you’re approved.

Does the Pfizer savings card really get me to $25?

Only if your eligible copay is $135 or less. Pfizer’s published terms cap Duavee savings at $110 per fill, so a $250 copay becomes $140, not $25. The card reduces an eligible commercial-insurance copay — it is not a substitute for plan coverage, and it requires private commercial insurance with Duavee coverage.

Every page on this topic quotes “as little as $25.” We did the arithmetic instead.

Calculated from Pfizer’s current $110-per-fill maximum, read July 28, 2026. Pharmacy adjudication, program limits, and any plan prohibition on manufacturer cards still apply.

The shared annual cap most women don’t see coming

Pfizer’s card covers a portfolio, not just Duavee. Per-fill maximums, from Pfizer’s own terms:

They share one annual maximum: $1,440 per calendar year.Duavee alone at the maximum runs $1,320 a year. That fits. But Duavee is not approved to treat vaginal dryness or painful sex — so some women on Duavee are also using a separately prescribed local product for genitourinary symptoms. If more than one eligible Pfizer product runs through the same card, every redemption counts against that shared cap. An illustrative calculation: two Estring benefits at $360 plus eight Duavee benefits at $110 is $1,600. The cap is gone before December.

Who qualifies for Pfizer’s patient assistance program?

Duavee is listed among the medicines remaining in the Pfizer Patient Assistance Program as of January 1, 2026. The program is for uninsured or publicly insured patients at or below 300% of the federal poverty level. Commercially insured patients are not eligible regardless of their coverage.

What the program requires:

• Annual pre-tax household income at or below 300% of the federal poverty level
• A valid prescription for an FDA-approved use of a Pfizer medicine in the program
• Being uninsured, or government-insured and unable to afford your copay — Medicare, Medicaid, TRICARE, and VA all count as government insurance here
• Commercially insured patients are not eligible — including through a job or federal employer plan

Apply or check current requirements at Pfizer RxPathways, or call 1-844-989-7284.

My plan denied Duavee. What happens next?

A denial is a starting position, not a verdict. For a Part D drug that is non-formulary and hasn’t had a coverage determination yet, the route is a formulary exception request. If that is denied — or a prior authorization is denied — the next route is an appeal under the denial notice. Your written notice identifies the controlling process and deadline.

Match the message to the fix

Exception first, appeal second

People use these words interchangeably. Insurers don’t.

• A coverage determination or formulary exception request asks the plan to cover something it currently doesn’t. That happens before any denial of that request.
• An appeal is what you file after an exception request or prior authorization is denied.

Filing the wrong one costs weeks. If your drug isn’t on the formulary and nobody has asked yet, you need an exception.

What the exception request has to say

The standard is narrower than most people assume. The prescriber’s supporting statement has to establish that the covered alternatives have been or are likely to be less effective for you, or have caused or are likely to cause you adverse effects.“She prefers it” isn’t the standard. The statement has to connect to effectiveness or harm.

State law may override the step requirement

Illinois’s Healthcare Protection Act (House Bills 5395 and 5295), effective January 1, 2026 for impacted plans, gives Illinois-licensed physicians authority to prescribe medically necessary drugs when step therapy requirements would otherwise apply. Centene’s policy explicitly notes Illinois overrides. If you’re in a state with step-therapy override law, ask your prescriber and insurer how it applies to your specific plan.

Why does Duavee work differently from other HRT combinations?

Duavee pairs conjugated estrogens with bazedoxifene, a selective estrogen receptor modulator (SERM). Per the FDA label, the bazedoxifene component reduces the risk of endometrial hyperplasia that can occur with the conjugated estrogens component — replacing the role a progestogen would play in a standard combination HRT.

Most menopause hormone therapy for a woman with a uterus pairs estrogen with a progestogen, because estrogen on its own can thicken the uterine lining. Duavee does that job differently. This is exactly why women who can’t tolerate progestins end up on it.

And it’s why step therapy that routes you back to estrogen-progestin combinations can feel circular. When a policy says “document two estrogen products first” and the alternatives it names include Prempro and Premphase — both of which contain a progestin — it’s pointing back at the category you may be trying to avoid. The intolerance documentation in the previous section is your path through that.

Duavee’s two FDA-approved uses: (1) moderate-to-severe vasomotor symptoms due to menopause, and (2) prevention of postmenopausal osteoporosis. The step-therapy alternatives differ depending on which use is the primary indication. Make sure the PA submission matches the indication your prescriber is treating.

What do other women say about the coverage side of Duavee?

Patient reviews are user-reported, drawn from small samples, and not evidence of how a medication will work for anyone. On WebMD in July 2026, Duavee showed 73 reviews; on Drugs.com, 35. Among those reviews, coverage and cost complaints appear alongside symptom reports.

“My insurance quit paying for it.”

“[My] monthly savings dropped from $75 to $70 while my fill price climbed.”

In comments on The Vajenda, by OB-GYN Dr. Jen Gunter, women describe why they end up on this drug: bioidentical estrogen-progesterone combinations causing endometrial thickening even at low doses; progesterone causing tiredness, mood changes, and anxiety. These are real people describing real experiences. They aren’t medical evidence, they don’t predict your results, and we’re not presenting them as typical.

Individual experiences from anonymous public reviews. Not clinical evidence and not typical results.

How The HRT Index verified this page

This page was produced by downloading and reading three named 2026 payer coverage policies plus one unattributed criteria document, the current FDA label, Pfizer’s published savings card terms and patient assistance criteria, FDA drug listing records, and the 2026 Express Scripts National Preferred Formulary. Commercial facts are traced to dated primary sources. This is editorial research and was not reviewed by a clinician.

Verified firsthand on July 28, 2026:

• Duavee prescribing information — DailyMed, revised 3/2024; checked July 28, 2026
• FDA National Drug Code Directory — Duavee NDC 0008-1123 (NDA 022247); generic-status check via Drugs@FDA and FDA Orange Book
• BCBS Arizona Pharmacy Coverage Guideline P140.2, Duavee — last reviewed November 20, 2025
• Centene Clinical Policy CP.PMN.258 — last reviewed February 2026
• Kaiser Foundation Health Plan of the Northwest criteria for conjugated equine estrogens–bazedoxifene— revised January 8, 2026, effective March 5, 2026
• Fourth criteria document dated February 23, 2026; issuing plan not identified in the document
• 2026 Express Scripts National Preferred Formulary and 2026 National Preferred Formulary Exclusions
• Pfizer Menopause Hormone Therapies Co-pay Savings Card — terms and conditions, read July 28, 2026
• Pfizer RxPathways — 2026 program updates and product list
• Illinois HB 5395 and HB 5295 — effective January 1, 2026

What we could not verify:

• Coverage under your specific plan, employer, or managed care arrangement
• Your exact out-of-pocket cost at your pharmacy
• Whether Pfizer’s patient assistance program has changed its product list or eligibility since January 1, 2026
• Duavee’s formulary status under every 2026 plan

Frequently asked questions about Duavee insurance coverage

Still not sure which HRT path is right for you?

The coverage question and the “is this the right drug for me” question are different. You’ve just mapped the coverage side. If the underlying fit question is still open — route, progestogen tolerance, provider, state, insurance — use the quiz.

Sources

The HRT Index is the independent decision resource for online menopause and HRT care. This page is educational and is not medical advice. It was not reviewed by a clinician — see our medical review policy, editorial standards, and corrections policy. We may earn a commission from some links, disclosed at the link. Talk to a qualified clinician about your own care.

Related pages: Duavee cost without insurance · Does insurance cover Angeliq? · Does insurance cover HRT for menopause? · Duavee online prescription · What to do if insurance denies HRT